MediWound to Report Third Quarter 2026 Financial Results
Globe Newswire•29/10/2026•08:00 ET
0
Key Highlights
- ➤MediWound will release Q3 2026 financial results on November 12, 2026
- ➤Management will host a financial-results conference call at 8:30 a.m. Eastern Time
- ➤NexoBrid is marketed in the United States, European Union, Japan, and additional international markets
- ➤EscharEx remains a late-stage investigational therapy for chronic-wound debridement
Conference Call and Webcast Scheduled for Thursday, November 12(th) at 8:30 a.m. Eastern Time
YAVNE, Israel, October 29, 2026 -- MediWound Ltd. (Nasdaq: MDWD), a global leader in next-generation enzymatic therapeutics for tissue repair, today announced that it will release its financial results for the third quarter ended September 30, 2026, on Thursday, November 12, 2026.
Get started
Create a free account to read the full story.